In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Avadel Pharmaceuticals plc (NASDAQ: AVDL) closed at $15.80 down -4.01% from its previous closing price of $16.46. In other words, the price has decreased by -$4.01 from its previous closing price. On the day, 0.54 million shares were traded. AVDL stock price reached its highest trading level at $16.55 during the session, while it also had its lowest trading level at $15.74.
Ratios:
For a deeper understanding of Avadel Pharmaceuticals plc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.52 and its Current Ratio is at 2.82. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 12, 2024, initiated with a Buy rating and assigned the stock a target price of $27.
On March 05, 2024, Oppenheimer reiterated its Outperform rating and also lowered its target price recommendation from $27 to $29.
Needham reiterated its Buy rating for the stock on March 05, 2024, while the target price for the stock was revised from $20 to $22.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 16 ’24 when MCHUGH THOMAS S bought 2,000 shares for $14.50 per share. The transaction valued at 29,000 led to the insider holds 80,500 shares of the business.
McCamish Mark Anthony sold 75,000 shares of AVDL for $1,089,750 on Dec 28 ’23. The Director now owns 67,025 shares after completing the transaction at $14.53 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVDL now has a Market Capitalization of 1521073792 and an Enterprise Value of 1487359360. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.99 while its Price-to-Book (P/B) ratio in mrq is 21.63. Its current Enterprise Value per Revenue stands at 15.632 whereas that against EBITDA is -15.297.
Stock Price History:
Over the past 52 weeks, AVDL has reached a high of $19.09, while it has fallen to a 52-week low of $9.50. The 50-Day Moving Average of the stock is 0.13%, while the 200-Day Moving Average is calculated to be 4.18%.
Shares Statistics:
For the past three months, AVDL has traded an average of 1.22M shares per day and 602060 over the past ten days. A total of 96.27M shares are outstanding, with a floating share count of 90.34M. Insiders hold about 6.16% of the company’s shares, while institutions hold 71.57% stake in the company. Shares short for AVDL as of 1722384000 were 11368919 with a Short Ratio of 9.66, compared to 1719532800 on 8465243. Therefore, it implies a Short% of Shares Outstanding of 11368919 and a Short% of Float of 13.520001.
